News

News-Medical.Net on MSN11h
Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Risk for dementia, ischemic stroke, mortality lower with GLP-1 receptor agonists in type 2 diabetes, obesity
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...
Ophthalmology Advisor48m
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...